Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Argos Therapeutics Company Profile (NASDAQ:ARGS)

Consensus Ratings for Argos Therapeutics (NASDAQ:ARGS) (?)
Ratings Breakdown: 1 Hold Rating(s), 4 Buy Rating(s)
Consensus Rating:Buy (Score: 2.80)
Consensus Price Target: $15.40 (81.18% upside)

Analysts' Ratings History for Argos Therapeutics (NASDAQ:ARGS)
Show:
DateFirmActionRatingPrice TargetDetailsShare
8/27/2014ZacksDowngradeNeutral$9.00ViewTweet This Rating  Share This Rating on StockTwits
8/19/2014Stifel NicolausInitiated CoverageBuy$16.00ViewTweet This Rating  Share This Rating on StockTwits
3/4/2014Stifel NicolausInitiated CoverageBuy -> Buy$16.00ViewTweet This Rating  Share This Rating on StockTwits
3/4/2014Piper JaffrayInitiated CoverageOverweight$18.00ViewTweet This Rating  Share This Rating on StockTwits
3/4/2014JMP SecuritiesInitiated CoverageOutperform$17.00ViewTweet This Rating  Share This Rating on StockTwits
3/4/2014Needham & Company LLCInitiated CoverageBuy$17.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 11/24/2012 forward)